Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study.
Saved in:
| Title: | Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study. |
|---|---|
| Authors: | Tsimikas S; University of California San Diego, La Jolla, CA, USA; Isis Pharmaceuticals, Carlsbad, CA, USA. Electronic address: stsimikas@ucsd.edu., Viney NJ; Isis Pharmaceuticals, Carlsbad, CA, USA., Hughes SG; Isis Pharmaceuticals, Carlsbad, CA, USA., Singleton W; Isis Pharmaceuticals, Carlsbad, CA, USA., Graham MJ; Isis Pharmaceuticals, Carlsbad, CA, USA., Baker BF; Isis Pharmaceuticals, Carlsbad, CA, USA., Burkey JL; Isis Pharmaceuticals, Carlsbad, CA, USA., Yang Q; Isis Pharmaceuticals, Carlsbad, CA, USA., Marcovina SM; University of Washington, Seattle, WA, USA., Geary RS; Isis Pharmaceuticals, Carlsbad, CA, USA., Crooke RM; Isis Pharmaceuticals, Carlsbad, CA, USA., Witztum JL; University of California San Diego, La Jolla, CA, USA. |
| Source: | Lancet (London, England) [Lancet] 2015 Oct 10; Vol. 386 (10002), pp. 1472-83. Date of Electronic Publication: 2015 Jul 22. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 26210642 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tsimikas+S%22">Tsimikas S</searchLink>; University of California San Diego, La Jolla, CA, USA; Isis Pharmaceuticals, Carlsbad, CA, USA. Electronic address: stsimikas@ucsd.edu.<br /><searchLink fieldCode="AU" term="%22Viney+NJ%22">Viney NJ</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+SG%22">Hughes SG</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Singleton+W%22">Singleton W</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Graham+MJ%22">Graham MJ</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Baker+BF%22">Baker BF</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Burkey+JL%22">Burkey JL</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+Q%22">Yang Q</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Marcovina+SM%22">Marcovina SM</searchLink>; University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Geary+RS%22">Geary RS</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Crooke+RM%22">Crooke RM</searchLink>; Isis Pharmaceuticals, Carlsbad, CA, USA.<br /><searchLink fieldCode="AU" term="%22Witztum+JL%22">Witztum JL</searchLink>; University of California San Diego, La Jolla, CA, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%222985213R%22">Lancet (London, England)</searchLink> [Lancet] 2015 Oct 10; Vol. 386 (10002), pp. 1472-83. <i>Date of Electronic Publication: </i>2015 Jul 22. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>2985213R <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-547X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201406736%22">01406736 </searchLink><i>NLM ISO Abbreviation: </i>Lancet <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=26210642 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S0140-6736(15)61252-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1472 Titles: – TitleFull: Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tsimikas S – PersonEntity: Name: NameFull: Viney NJ – PersonEntity: Name: NameFull: Hughes SG – PersonEntity: Name: NameFull: Singleton W – PersonEntity: Name: NameFull: Graham MJ – PersonEntity: Name: NameFull: Baker BF – PersonEntity: Name: NameFull: Burkey JL – PersonEntity: Name: NameFull: Yang Q – PersonEntity: Name: NameFull: Marcovina SM – PersonEntity: Name: NameFull: Geary RS – PersonEntity: Name: NameFull: Crooke RM – PersonEntity: Name: NameFull: Witztum JL IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 10 Text: 2015 Oct 10 Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1474-547X Numbering: – Type: volume Value: 386 – Type: issue Value: 10002 Titles: – TitleFull: Lancet (London, England) Type: main |
| ResultId | 1 |